 Maggie Lam
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 29 | 2025 | 1111 | 5.060 |
Why?
| | Proteome | 19 | 2025 | 472 | 3.720 |
Why?
| | Myocardium | 12 | 2025 | 1002 | 2.970 |
Why?
| | Alternative Splicing | 5 | 2025 | 229 | 2.280 |
Why?
| | Protein Isoforms | 4 | 2025 | 404 | 1.750 |
Why?
| | Proteins | 8 | 2025 | 1009 | 1.490 |
Why?
| | Mitochondria, Heart | 7 | 2016 | 102 | 1.450 |
Why?
| | Bibliometrics | 3 | 2019 | 63 | 1.300 |
Why?
| | Heart | 2 | 2025 | 655 | 1.050 |
Why?
| | Muscle Proteins | 5 | 2016 | 231 | 0.980 |
Why?
| | Mitochondrial Proteins | 5 | 2015 | 257 | 0.910 |
Why?
| | Chromatography, Reverse-Phase | 4 | 2012 | 28 | 0.890 |
Why?
| | Computational Biology | 2 | 2021 | 644 | 0.860 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2024 | 34 | 0.850 |
Why?
| | Proteogenomics | 1 | 2022 | 6 | 0.780 |
Why?
| | Data Mining | 3 | 2019 | 116 | 0.770 |
Why?
| | Disease | 2 | 2020 | 98 | 0.720 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2111 | 0.720 |
Why?
| | Paraquat | 1 | 2020 | 14 | 0.690 |
Why?
| | Robotics | 1 | 2021 | 94 | 0.670 |
Why?
| | Mass Spectrometry | 9 | 2025 | 739 | 0.640 |
Why?
| | Heart Diseases | 1 | 2023 | 346 | 0.640 |
Why?
| | Semantics | 1 | 2018 | 92 | 0.570 |
Why?
| | Quinolines | 1 | 2018 | 178 | 0.520 |
Why?
| | Down Syndrome | 1 | 2023 | 496 | 0.510 |
Why?
| | Oxidative Stress | 2 | 2020 | 1317 | 0.480 |
Why?
| | Deuterium Oxide | 4 | 2025 | 16 | 0.480 |
Why?
| | Mice | 22 | 2025 | 17787 | 0.470 |
Why?
| | Research | 2 | 2015 | 451 | 0.470 |
Why?
| | Cardiovascular System | 2 | 2016 | 137 | 0.450 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2014 | 156 | 0.440 |
Why?
| | Ubiquitination | 1 | 2014 | 102 | 0.440 |
Why?
| | Cardiology | 1 | 2016 | 274 | 0.430 |
Why?
| | Biomedical Research | 2 | 2018 | 692 | 0.430 |
Why?
| | Isoproterenol | 1 | 2014 | 113 | 0.420 |
Why?
| | Animals | 31 | 2025 | 36940 | 0.420 |
Why?
| | Cyclophilins | 1 | 2013 | 40 | 0.420 |
Why?
| | Biomarkers | 4 | 2021 | 4149 | 0.390 |
Why?
| | Glycopeptides | 2 | 2011 | 43 | 0.380 |
Why?
| | Lysine | 1 | 2014 | 294 | 0.380 |
Why?
| | Glycomics | 1 | 2011 | 8 | 0.370 |
Why?
| | Graphite | 1 | 2011 | 13 | 0.370 |
Why?
| | Glycoproteins | 2 | 2010 | 342 | 0.360 |
Why?
| | Myocytes, Cardiac | 4 | 2025 | 526 | 0.320 |
Why?
| | Tandem Mass Spectrometry | 4 | 2021 | 532 | 0.310 |
Why?
| | Deuterium | 2 | 2025 | 99 | 0.280 |
Why?
| | Humans | 30 | 2025 | 137585 | 0.270 |
Why?
| | Amino Acid Sequence | 6 | 2014 | 2139 | 0.260 |
Why?
| | Chromatography, Liquid | 4 | 2012 | 433 | 0.250 |
Why?
| | Isotope Labeling | 2 | 2025 | 81 | 0.250 |
Why?
| | Peptides | 5 | 2025 | 985 | 0.240 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 2900 | 0.240 |
Why?
| | Tensins | 1 | 2024 | 5 | 0.220 |
Why?
| | LIM Domain Proteins | 1 | 2024 | 21 | 0.220 |
Why?
| | Proteostasis | 1 | 2024 | 29 | 0.210 |
Why?
| | Aging | 3 | 2023 | 1864 | 0.210 |
Why?
| | Heart Ventricles | 3 | 2024 | 788 | 0.210 |
Why?
| | Organ Specificity | 1 | 2024 | 305 | 0.210 |
Why?
| | Heart Atria | 1 | 2024 | 137 | 0.200 |
Why?
| | Databases, Protein | 2 | 2013 | 85 | 0.200 |
Why?
| | Cell Culture Techniques | 1 | 2025 | 363 | 0.200 |
Why?
| | Transcriptome | 4 | 2022 | 971 | 0.200 |
Why?
| | Cell Line | 4 | 2019 | 2847 | 0.190 |
Why?
| | Polysaccharides | 3 | 2011 | 79 | 0.190 |
Why?
| | Myofibrils | 1 | 2022 | 50 | 0.190 |
Why?
| | Sarcomeres | 1 | 2022 | 96 | 0.190 |
Why?
| | Muscle, Striated | 1 | 2021 | 5 | 0.190 |
Why?
| | Automation | 1 | 2021 | 95 | 0.180 |
Why?
| | Heart Failure | 3 | 2022 | 2236 | 0.180 |
Why?
| | Ventricular Remodeling | 2 | 2021 | 266 | 0.180 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2025 | 248 | 0.180 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.180 |
Why?
| | Blood Proteins | 2 | 2014 | 252 | 0.180 |
Why?
| | Cyclic N-Oxides | 1 | 2020 | 29 | 0.170 |
Why?
| | Equipment Design | 3 | 2011 | 522 | 0.170 |
Why?
| | Male | 11 | 2023 | 67762 | 0.170 |
Why?
| | Spin Labels | 1 | 2020 | 48 | 0.170 |
Why?
| | RNA Splicing | 1 | 2022 | 269 | 0.170 |
Why?
| | Laboratories | 1 | 2021 | 113 | 0.170 |
Why?
| | RNA-Binding Proteins | 2 | 2022 | 422 | 0.170 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 81 | 0.170 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2025 | 860 | 0.170 |
Why?
| | Respiratory Hypersensitivity | 1 | 2020 | 69 | 0.170 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 80 | 0.160 |
Why?
| | Specimen Handling | 1 | 2021 | 183 | 0.160 |
Why?
| | Embryonic Stem Cells | 1 | 2021 | 129 | 0.160 |
Why?
| | Protein Binding | 2 | 2024 | 2224 | 0.160 |
Why?
| | Organophosphorus Compounds | 1 | 2020 | 78 | 0.160 |
Why?
| | Extracellular Matrix | 2 | 2021 | 528 | 0.160 |
Why?
| | Cardiomegaly | 2 | 2018 | 175 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 210 | 0.160 |
Why?
| | Doxorubicin | 1 | 2021 | 362 | 0.150 |
Why?
| | Cell Differentiation | 3 | 2025 | 1991 | 0.150 |
Why?
| | Signal Transduction | 1 | 2012 | 5079 | 0.150 |
Why?
| | Piperidines | 1 | 2020 | 206 | 0.150 |
Why?
| | Rheumatic Diseases | 1 | 2019 | 81 | 0.150 |
Why?
| | Proteolysis | 2 | 2025 | 177 | 0.150 |
Why?
| | Molecular Sequence Annotation | 1 | 2018 | 99 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2019 | 127 | 0.140 |
Why?
| | Sex Characteristics | 1 | 2023 | 762 | 0.140 |
Why?
| | Phosphorylation | 2 | 2012 | 1759 | 0.140 |
Why?
| | Female | 8 | 2025 | 73304 | 0.140 |
Why?
| | Mitochondria | 2 | 2015 | 948 | 0.130 |
Why?
| | Early Diagnosis | 1 | 2018 | 242 | 0.130 |
Why?
| | Kinetics | 2 | 2025 | 1670 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 455 | 0.130 |
Why?
| | Brain Chemistry | 1 | 2016 | 117 | 0.120 |
Why?
| | Alu Elements | 1 | 2016 | 28 | 0.120 |
Why?
| | Machine Learning | 1 | 2021 | 493 | 0.120 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 460 | 0.120 |
Why?
| | Chromatin | 1 | 2019 | 519 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3284 | 0.120 |
Why?
| | Primates | 1 | 2016 | 126 | 0.110 |
Why?
| | Eye | 1 | 2015 | 108 | 0.110 |
Why?
| | Nuclear Proteins | 1 | 2019 | 712 | 0.110 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2011 | 187 | 0.110 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 119 | 0.110 |
Why?
| | Chloroplasts | 2 | 2011 | 17 | 0.110 |
Why?
| | Cattle | 3 | 2012 | 984 | 0.110 |
Why?
| | Acetylation | 1 | 2014 | 248 | 0.100 |
Why?
| | Knowledge Bases | 1 | 2013 | 27 | 0.100 |
Why?
| | Systems Integration | 1 | 2013 | 37 | 0.100 |
Why?
| | Genome, Human | 1 | 2016 | 425 | 0.100 |
Why?
| | Adrenergic beta-Agonists | 1 | 2014 | 134 | 0.100 |
Why?
| | Intestines | 1 | 2016 | 357 | 0.100 |
Why?
| | Systems Biology | 1 | 2013 | 67 | 0.100 |
Why?
| | Arabidopsis Proteins | 2 | 2011 | 75 | 0.100 |
Why?
| | Peptide Library | 1 | 2013 | 92 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 1040 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2012 | 73 | 0.100 |
Why?
| | Switzerland | 1 | 2012 | 37 | 0.090 |
Why?
| | Carbohydrate Conformation | 1 | 2011 | 11 | 0.090 |
Why?
| | Calcium Signaling | 1 | 2014 | 249 | 0.090 |
Why?
| | Concanavalin A | 1 | 2011 | 76 | 0.090 |
Why?
| | International Cooperation | 1 | 2012 | 198 | 0.090 |
Why?
| | Peptide Mapping | 1 | 2011 | 64 | 0.090 |
Why?
| | Peptide Hydrolases | 1 | 2012 | 111 | 0.090 |
Why?
| | Protein Conformation | 1 | 2014 | 934 | 0.090 |
Why?
| | Chromatography, Ion Exchange | 1 | 2011 | 55 | 0.090 |
Why?
| | Transcription Factors | 1 | 2019 | 1719 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 431 | 0.090 |
Why?
| | Serum | 1 | 2010 | 59 | 0.080 |
Why?
| | Oryza | 1 | 2010 | 33 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 433 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2010 | 239 | 0.080 |
Why?
| | Plant Proteins | 1 | 2010 | 113 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2010 | 385 | 0.080 |
Why?
| | Nitric Oxide Synthase | 1 | 2010 | 240 | 0.080 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 180 | 0.080 |
Why?
| | Arabidopsis | 1 | 2010 | 95 | 0.080 |
Why?
| | Models, Molecular | 1 | 2014 | 1570 | 0.080 |
Why?
| | Kidney | 1 | 2016 | 1468 | 0.070 |
Why?
| | Liver | 1 | 2016 | 1943 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 597 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2011 | 706 | 0.070 |
Why?
| | Rats | 3 | 2022 | 5647 | 0.060 |
Why?
| | Algorithms | 1 | 2013 | 1704 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2025 | 4193 | 0.060 |
Why?
| | Fibroblasts | 2 | 2025 | 996 | 0.060 |
Why?
| | Unfolded Protein Response | 1 | 2024 | 59 | 0.050 |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3412 | 0.050 |
Why?
| | Lung | 1 | 2016 | 4060 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2021 | 2057 | 0.050 |
Why?
| | Histone Deacetylase 6 | 1 | 2022 | 17 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2022 | 2607 | 0.050 |
Why?
| | Connectin | 1 | 2022 | 33 | 0.050 |
Why?
| | Cats | 1 | 2022 | 210 | 0.050 |
Why?
| | Water | 1 | 2025 | 460 | 0.050 |
Why?
| | Cardiotoxicity | 1 | 2021 | 26 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4295 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 25 | 0.040 |
Why?
| | Human Genome Project | 1 | 2020 | 15 | 0.040 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2020 | 33 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 367 | 0.040 |
Why?
| | Teratoma | 1 | 2021 | 114 | 0.040 |
Why?
| | Software | 1 | 2025 | 665 | 0.040 |
Why?
| | Cell Death | 1 | 2021 | 374 | 0.040 |
Why?
| | Stroke Volume | 1 | 2022 | 612 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2020 | 313 | 0.040 |
Why?
| | Azepines | 1 | 2019 | 90 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2022 | 534 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2020 | 273 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 283 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 181 | 0.040 |
Why?
| | Homeostasis | 2 | 2012 | 621 | 0.040 |
Why?
| | Atrial Remodeling | 1 | 2018 | 9 | 0.040 |
Why?
| | Triazoles | 1 | 2019 | 147 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 622 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 190 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2020 | 319 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5757 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2018 | 200 | 0.030 |
Why?
| | Osteoarthritis | 1 | 2019 | 185 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2018 | 409 | 0.030 |
Why?
| | Fibrosis | 1 | 2019 | 552 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 480 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2019 | 324 | 0.030 |
Why?
| | RNA Editing | 1 | 2016 | 24 | 0.030 |
Why?
| | Adenosine Deaminase | 1 | 2016 | 36 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 305 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1272 | 0.030 |
Why?
| | RNA Stability | 1 | 2016 | 117 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 585 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2022 | 2833 | 0.030 |
Why?
| | Exons | 1 | 2016 | 355 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 660 | 0.030 |
Why?
| | Mammals | 1 | 2016 | 283 | 0.030 |
Why?
| | Adult | 2 | 2014 | 37929 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2486 | 0.030 |
Why?
| | Software Design | 1 | 2013 | 24 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2475 | 0.030 |
Why?
| | Access to Information | 1 | 2013 | 49 | 0.030 |
Why?
| | Diffusion of Innovation | 1 | 2013 | 99 | 0.020 |
Why?
| | Smoking | 1 | 2020 | 1627 | 0.020 |
Why?
| | Half-Life | 1 | 2012 | 164 | 0.020 |
Why?
| | Cytoprotection | 1 | 2012 | 56 | 0.020 |
Why?
| | Drosophila | 1 | 2013 | 154 | 0.020 |
Why?
| | Enzyme Stability | 1 | 2012 | 70 | 0.020 |
Why?
| | Workflow | 1 | 2013 | 165 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 539 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 114 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2553 | 0.020 |
Why?
| | Oxidants | 1 | 2012 | 111 | 0.020 |
Why?
| | Automation, Laboratory | 1 | 2011 | 7 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1724 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2012 | 372 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 304 | 0.020 |
Why?
| | Cations | 1 | 2011 | 84 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2011 | 167 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1774 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 2019 | 1167 | 0.020 |
Why?
| | Suppression, Genetic | 1 | 2010 | 25 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2010 | 67 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 328 | 0.020 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 28 | 0.020 |
Why?
| | Ribonucleases | 1 | 2010 | 55 | 0.020 |
Why?
| | Caenorhabditis elegans | 1 | 2013 | 306 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2016 | 922 | 0.020 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2010 | 65 | 0.020 |
Why?
| | Trypsin | 1 | 2010 | 77 | 0.020 |
Why?
| | GTP Phosphohydrolases | 1 | 2010 | 93 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2011 | 560 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 343 | 0.020 |
Why?
| | Solvents | 1 | 2010 | 109 | 0.020 |
Why?
| | Serum Albumin | 1 | 2010 | 150 | 0.020 |
Why?
| | Protein Transport | 1 | 2010 | 445 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2012 | 405 | 0.020 |
Why?
| | RNA Interference | 1 | 2010 | 469 | 0.020 |
Why?
| | Zebrafish Proteins | 1 | 2011 | 288 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2012 | 557 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 665 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 1916 | 0.010 |
Why?
| | Mutation | 1 | 2010 | 3958 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 13209 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 33479 | 0.010 |
Why?
|
|
Lam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|